Behemoth Merger by End of the Month?
The $43 billion mega-merger of Medtronic and Covidien could see completed by January 29, according to a regulatory filing dated January 12, 2015.
According to the filing:
“Covidien plc announced that the Irish High Court has set January 26, 2015 to hear the Company’s petition to sanction the scheme of arrangement under which Medtronic, Inc. will acquire the Company. This action follows a hearing before the Irish High Court earlier today. If the Irish High Court sanctions the scheme of arrangement at the January 26, 2015 hearing, the Transaction is expected to close on or prior to January 29, 2015.”
The merger has been approved by shareholders of both companies and all regulatory agencies.
Related Articles
-
“We are honored to have Dr. Lace, who is widely recognized as one of the industry’s most trusted reimbursement experts, leading our new division. He will also support all our services as our CMO.”
-
“Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities” offers key recommendations for device manufacturers and developers on steps they can take to increase diversity in clinical research and address health equity.
-
Market research and forecasting help ensure that you are investing in a device or drug that is needed and will be well received. In this article, Sanobar Syed, Associate Director of Forecasting, Market Insights and Strategies, BeiGene, highlights strategies to…
-
AI not only improves data collection and analysis, it impacts which products are engaged in clinical trials, determines necessary medical criteria, helps design the trials and can even choose the best participating facilities. The result is, organizations that leverage AI…
